Sorafenib (Nexavarl®) with metastasis sarcomatoid renal cell cancer after failure of a previous chemotherapy with Doxorubicin and Gemcitabine

被引：0
|
作者：
Staehler, M. [1 ]
Schoeppler, G. [1 ]
Haseke, N. [1 ]
Stadler, T. [1 ]
Karl, A. [1 ]
Stief, C. G. [1 ]
机构：
[1] Univ Munich, Urol Klin, Munich, Germany
来源：
ONKOLOGIE | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [21] Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy
    Janice P. Dutcher
    David Nanus
    Medical Oncology, 2011, 28 : 1530 - 1533
  • [22] A Retrospective Study of Chemotherapy with Cisplatin Plus Gemcitabine After the Failure of Gemcitabine Monotherapy for Biliary Tract Cancer
    Kameda, Ryo
    Ando, Tomoko
    Kobayashi, Satoshi
    Ueno, Makoto
    Ohkawa, Shinichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (06) : 636 - 640
  • [23] Efficacy and toxicity of pegylated liposomal doxorubicin as therapy for recurrent ovarian cancer in relation to the number of previous chemotherapy regimens: Comparison with gemcitabine
    Takahashi, Yoshifumi
    Takei, Yuji
    Machida, Shizuo
    Taneichi, Akiyo
    Takahashi, Suzuyo
    Yoshiba, Takahiro
    Koyanagi, Takahiro
    Tamura, Kohei
    Saga, Yasushi
    Fujiwara, Hiroyuki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (02) : 551 - 559
  • [24] EVALUATION OF CHEMOTHERAPY WITH CISPLATIN-GEMCITABINE AFTER FAILURE OF GEMCITABINE MONOTHERAPY FOR UNRESECTABLE OR RECURRENT BILIARY TRACT CANCER
    Kameda, R.
    Ando, T.
    Kobayashi, S.
    Ueno, M.
    Ohkawa, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 162 - 162
  • [25] CHEMOTHERAPY WITH CPT-11 AFTER GEMCITABINE FAILURE IN PATIENTS WITH ADVANCED PANCREATIC CANCER
    Kaneda, Hiroyasu
    Ueda, Shinya
    Makimura, Chihiro
    Kiyota, Hidemi
    Kawakami, Hisato
    Okamoto, Isamu
    Tanaka, Kaoru
    Nishina, Shinichi
    Kudo, Toshihiro
    Turutani, Junji
    Miyazaki, Masaki
    Fujisaka, Yasuhito
    Okamoto, Wataru
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    ANNALS OF ONCOLOGY, 2012, 23 : 65 - 65
  • [26] Risk factors for heart failure after doxorubicin chemotherapy for breast- or colorectal cancer
    Fogarassy, G.
    Vathy-Fogarassy, A.
    Hornyak, L.
    Forster, T.
    EUROPEAN HEART JOURNAL, 2017, 38 : 406 - 406
  • [27] Evaluation of chemotherapy with cisplatin plus gemcitabine after failure of gemcitabine alone for unresectable or recurrent biliary tract cancer.
    Kameda, Ryo
    Ando, Tomoko
    Kobayashi, Satoshi
    Ueno, Makoto
    Ohkawa, Shinichi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [28] Everolimus in metastatic renal cell cancer after sunitinib/sorafenib: a new standard for kidney cancer
    Massard, Christophe
    Bay, Jacques-Olivier
    BULLETIN DU CANCER, 2009, 96 (03) : 256 - 256
  • [29] The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer
    Boeck, Stefan
    Heinemann, Volker
    FUTURE ONCOLOGY, 2008, 4 (01) : 41 - 50
  • [30] Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
    Chen, YM
    Perng, RP
    Lin, WC
    Wu, HW
    Tsai, CM
    Whang-Peng, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 509 - 512
12345